Does ADALIMUMAB Cause Type v hyperlipidaemia? 11 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Type v hyperlipidaemia have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.
11
Reports of Type v hyperlipidaemia with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Type v hyperlipidaemia From ADALIMUMAB?
Of the 11 reports, 2 (18.2%) required hospitalization.
Is Type v hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Type v hyperlipidaemia?
SACUBITRIL\VALSARTAN (25)
ASPIRIN (24)
CARVEDILOL (23)
ATORVASTATIN (22)
RAMIPRIL (22)
ALENDRONATE (21)
DAPAGLIFLOZIN (21)
ALLOPURINOL (19)
EPLERENONE (19)
EZETIMIBE (19)
Which ADALIMUMAB Alternatives Have Lower Type v hyperlipidaemia Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB